ABSTRACT
The aim of this work was to evaluate the direct protective action of oral fatty acid supplementation against the deleterious effect of hyperglycemia on maternal reproductive outcomes; fetal growth and development on female Wistar rats. The animals were distributed into four experimental groups: G1= non-diabetic without supplementation (Control group); G2= non-diabetic treated with linoleic (LA) and gammalinolenic acid (GLA) (1 mL of Gamaline-V/day); G3= diabetic without supplementation and G4= diabetic treated with LA and GLA. Diabetes was induced by streptozotocin (40 mg/kg). At day 21 of pregnancy, the gravid uterus was weighed and dissected to count the dead and live fetuses, resorption, implantation, and corpora lutea numbers. The fetuses were analyzed for external and internal anomalies. The treatment with Gamaline-V supplementation to diabetic rats interfered in the maternal reproductive outcome (reduced number of live fetuses and embryonic implantation); however, it protected the deleterious on the incidence of congenital anomalies caused by hyperglycemia.
ABSTRACT
The aim of this sstudy was to evaluate the liver glycogen storage in pregnant rats presenting neonatal streptozotocin-induced diabetes and to establish a relation with glycemia and insulin levels. Wistar rats were divided in to two groups: 1) Mild Diabetes (STZ) - received streptozotocin (glycemia from 120 to 300 mg/dL), 2) Control - received vehicle (glycemia below 120 mg/dL). At days 0, 7, 14 and 21 of the pregnancy, body weight and glycemia were evaluated. At day 21 of the pregnancy, the rats were anesthetized for blood and liver collection so as to determine insulin and liver glycogen, which showed no changes in the STZ group as compared to the controls. In the STZ group, maternal weight gain were lower as compared to those in the control group. Significantly increased glycemia was observed at days 0 and 14 of the pregnancy in the STZ group. Therefore, neonatally induced diabetes in the rats did not cause metabolic changes that impaired insulin and liver glycogen relation in these rats.
ABSTRACT
Muitas superstições são encontradas em nossas vidas. Na medicina, uma profissão que se orgulha em métodos baseados em evidências para tratamentos, isso não é uma exceção. Uma superstição que abrange o parto é a influência de determinadas fases do ciclo da lua, mais especificamente a lua cheia. Embora estudos tenham demonstrado que o aumento de partos está relacionado com o ciclo lunar, existe discordância sobre quando ocorre o pico do volume de partos em cada fase da lua. Frente à divergência de resultados existentes na literatura que relaciona os eventos do ciclo lunar com parto, o objetivo desta revisão foi realizar um levantamento bibliográfico na tentativa de esclarecer esta cultura popular com base nos resultados apresentados por diferentes autores.
Superstitions are found everywhere in our lives, and medicine, a profession that is prides itself on an evidence-based approach to treatment, is not exempt. A superstition that pervades the labor and delivery floor is that it is busier during certain phases of the lunar cycle, specifically the full moon. Although some studies have demonstrated an increase in deliveries that are related to the lunar cycle, there has been disagreement about when, in the lunar cycle, the peak volume occurs. Front to the divergence of the existent results in the literature to relate the events of the lunar cycle with deliveries, the aim of this review was to accomplish the literature in the attempt of explaining this popular culture with base in the results presented by different researchers.
Se encuentran las supersticiones por todas partes en nuestras vidas, y la medicina, una profesión que tiene orgullo acerca de los tratamientos con base en evidencia, no está extinta. La influencia de ciertas fases del ciclo lunar, específicamente la luna llena, es una superstición sobre el parto. Aunque algunos estudios han demostrado un aumento en los partos que se relacionan al ciclo lunar, ha habido discordancia sobre cuando, en el ciclo lunar, el volumen máximo ocurre. Afronte a la divergencia de los resultados existentes en la literatura que relacionan los eventos del ciclo lunar con los partos, el objetivo de esta revisión era explorar la literatura en el esfuerzo de explicar esta cultura popular con la base en los resultados presentado por los diferentes investigadores.
Subject(s)
Female , Humans , Pregnancy , Labor, Obstetric/physiology , Moon , SuperstitionsABSTRACT
Purpose: To evaluate the placental glycogen storage and fetal development in the pregnancy of neonatally streptozocin-induced diabetic rats and to establish relation with glycemia and insulin levels. Methods: At the birth day, 147 female rats were randomly distributed in two experimental groups: 1) Non-diabetic Group (Control, n=45) - received the vehicle; 2) Diabetic Group (STZ, n=102) - received 100 mg streptozocin/kg in neonatal period. At day 0 of pregnancy, adult female rats were included in the control group when presented glycemia below 120 mg/dL and, in the group STZ with glycemia between 120 and 300 mg/dL. At day 21 of pregnancy, blood samples were collected for glycemia and insulin determination, and placentas withdrawn for placental glycogen determination. The newborns (NB) were classified in small (SGA), appropriate (AGA) and large (LGA) for gestational age. Results: Rats STZ presented higher glycemia at days 0 and 14 of pregnancy. At end of pregnancy, rats STZ showed higher proportion of NB SGA and LGA; reduced rate of NB AGA and unaltered glycemia, insulin and placental glycogen determinations. Conclusion: Mild diabetes altered the maternal glycemia in the early pregnancy, impairing future fetal development, but it caused no alteration on insulin and placental glycogen determination, confirming that this glycemic intensity was insufficient to change glycogen metabolism.
Objetivo: Avaliar os estoques de glicogênio placentário e o desenvolvimento fetal na prenhez de ratas com diabete moderado induzido no período neonatal e relacionar com glicemia e níveis de insulina. Métodos: No dia de nascimento, foram distribuídas aleatoriamente 147 ratas em dois grupos experimentais: 1) Grupo Não-diabético (Controle, n=45) - recebeu o veículo; 2) Grupo Diabético (STZ, n=102) - recebeu 100 mg streptozocin/kg peso corpóreo. No dia 0 de prenhez, foram incluídas ratas controle que apresentassem glicemia baixo de 120 mg/dL e, no grupo STZ, com glicemia entre 120 e 300 mg/dL. No 21º dia de prenhez, amostras de sangue foram coletadas para glicemia e determinação de insulina e as placentas foram retiradas para determinação de glicogênio placentário. Os recém-nascidos (RN) foram classificados em pequeno (PIP), adequado (AIP) e grande (GIP) para idade de prenhez. Resultados: As ratas STZ apresentaram glicemias maiores nos dias 0 e 14 de prenhez. No final da prenhez, as ratas STZ mostraram maior proporção de RN PIP e GIP, taxa reduzida de RN AIP e inalteração em glicemia, insulina e na determinação de glicogênio placentário. Conclusão: O diabete moderado alterou a glicemia materna no início da prenhez, prejudicando o futuro desenvolvimento placentário e fetal, mas não causou nenhuma alteração na determinação de insulina e de glicogênio placentário, confirmando que esta intensidade de glicêmica foi insuficiente para modificar o metabolismo de glicogênio.